Clinical Trial Update: PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a PD-1 antibody in combination with Sapropterin Dihydrochloride for metastatic pancreatic adenocarcinoma, and the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: RECRUITING